IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Noncutaneous Extranodal Lymphoma

Northwestern Universitymonoclonal_antibodyPhase 2Dormant

63/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 48/ 100
Competitive Position: 95/ 100

Competitive context

0 Active assets in the Noncutaneous Extranodal Lymphoma cohort.

Asset / Sponsor	Phase	Rating
Fludarabine Case Comprehensive Cancer Center	Phase 2	BBB
CYCLOSPORIN A Fred Hutchinson Cancer Center	Phase 2	BB
Monomethyl Fumarate University of Medicine and Dentistry of New Jersey	Phase 2	BB
Cyclophosphamide Case Comprehensive Cancer Center	Phase 2	B
Busulphan Case Comprehensive Cancer Center	Phase 2	B

View all 36 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB